Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States

Documenti analoghi

• Elucidating the role of weight loss and glycaemic control in patients with type 2 diabetes
  di: Anukriti Sharma, et al.
  Pubblicazione: (2024)
• Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic
  di: Jason M. Samuels, et al.
  Pubblicazione: (2025)
• Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population
  di: Adam Buckley, et al.
  Pubblicazione: (2024)
• Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus
  di: Michael S. Kelly, et al.
  Pubblicazione: (2024)
• Weight loss in people with type 1 diabetes over 12 months: Real‐world data comparing tirzepatide, semaglutide and liraglutide
  di: Ebaa Al Ozairi, et al.
  Pubblicazione: (2025)